Atorvastatin
Also known as: atorvastatin calcium
Classification
Pharmaceutical
Regulatory Status
US prescription drug labeling exists for the named active ingredient. This record is not a substitute for the current label.
Overview
Atorvastatin is a labeled HMG-CoA reductase inhibitor. This record does not restate eligibility or a dose.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
Benefits
The DailyMed Lipitor label describes atorvastatin for labeled lipid and cardiovascular-risk indications.
Interactions & cautions
Flagged in source data
Drug interactions
strong CYP3A4 inhibitors — Strong CYP3A4 inhibitors increase atorvastatin exposure and myopathy risk. The current label, not this record, defines the restricted combinations. (review)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.